Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy.
Open Access
- 1 December 1989
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 42 (12) , 1255-1258
- https://doi.org/10.1136/jcp.42.12.1255
Abstract
The incidence of mucocutaneous herpes simplex virus infection confirmed by culture and occurring during febrile neutropenic episodes was determined in 43 patients with haematological malignancy. The outcome of 72 episodes of neutropenic fever was determined and correlated with the presence or absence of herpes simplex virus (HSV) infection. Twenty four patients had mucocutaneous HSV infection during at least one episode. In 24 episodes in which HSV was isolated only 12.5% of fevers responded to antibiotics and 75% of fevers were otherwise unexplained. Conversely, in 48 episodes of neutropenic fever in which HSV was not isolated 67% of fevers responded to antibiotics and only 8.3% were unexplained. The difference in incidence of antibiotic resistant fever in the two groups was significant. There was, therefore, a strong association between mucocutaneous HSV infection and antibiotic resistant fever in immunosuppressed neutropenic patients. As most HSV infections are the result of virus reactivation, establishing the HSV serological state of patients would identify those at risk of infection and hence those in whom the prophylactic use of acyclovir would be indicated.Keywords
This publication has 12 references indexed in Scilit:
- Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patientsAntimicrobial Agents and Chemotherapy, 1986
- Rational Basis for the Choice of Regimens for Empirical Therapy of Sepsis in Granulocytopenic PatientsClinics in Haematology, 1984
- Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trialBritish Journal of Cancer, 1984
- Acyclovir Prophylaxis Against Herpes Simplex Virus Infection in Patients with LeukemiaAnnals of Internal Medicine, 1983
- SEPTICAEMIA CAUSED BY VIRIDANS STREPTOCOCCI IN NEUTROPENIC PATIENTS WITH LEUKAEMIAThe Lancet, 1983
- PROPHYLAXIS OF HERPES INFECTIONS AFTER BONE-MARROW TRANSPLANTATION BY ORAL ACYCLOVIRThe Lancet, 1983
- Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.BMJ, 1983
- Intravenous Acyclovir to Treat Mucocutaneous Herpes Simplex Virus Infection After Marrow TransplantationAnnals of Internal Medicine, 1982
- Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies: A prospective studyCancer, 1981
- Cellular Immunity and Herpesvirus Infections in Cardiac-Transplant PatientsNew England Journal of Medicine, 1977